These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations. Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Nozad S; Sheehan CE; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Schrock AB; Hirshfield KM; Ali N; Ganesan S; Ali SM; Miller VA; Stephens PJ; Ross JS; Chung JH Breast Cancer Res Treat; 2017 Apr; 162(3):597-602. PubMed ID: 28210881 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences. Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083 [TBL] [Abstract][Full Text] [Related]
6. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584 [TBL] [Abstract][Full Text] [Related]
7. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study. Ross JS; Gay LM; Nozad S; Wang K; Ali SM; Boguniewicz A; Khaira D; Johnson A; Elvin JA; Vergilio JA; Suh J; Miller VA; Stephens PJ Breast Cancer Res Treat; 2016 Jan; 155(2):405-13. PubMed ID: 26762307 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options. Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808 [TBL] [Abstract][Full Text] [Related]
9. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma. Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling. Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies. Yakirevich E; Madison R; Fridman E; Mangray S; Carneiro BA; Lu S; Cooke M; Bratslavsky G; Webster J; Ross JS; Ali SM Eur Urol Oncol; 2021 Apr; 4(2):282-288. PubMed ID: 31412008 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations. Ross JS; Ali SM; Wang K; Khaira D; Palma NA; Chmielecki J; Palmer GA; Morosini D; Elvin JA; Fernandez SV; Miller VA; Stephens PJ; Cristofanilli M Breast Cancer Res Treat; 2015 Nov; 154(1):155-62. PubMed ID: 26458824 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420 [TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options. Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Comparative Study of Aggressive and Non-aggressive Central Giant Cell Lesions of the Jaws Based on the Tenascin-C Expression Profile. Tobón-Arroyave SI; Isaza-Guzmán DM; Flórez-Moreno GA J Histochem Cytochem; 2021 Jul; 69(7):475-484. PubMed ID: 34120502 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids, calcitonin, and osteocalcin cannot differentiate between aggressive and nonaggressive central giant cell lesions of the jaws. Martins AF; Souza PO; Rege IC; Morais MO; Mendonça EF Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):386-95. PubMed ID: 26188731 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers. Weinberg BA; Gowen K; Lee TK; Ou SI; Bristow R; Krill L; Almira-Suarez MI; Ali SM; Miller VA; Liu SV; Klempner SJ Oncologist; 2017 Feb; 22(2):152-157. PubMed ID: 28193735 [TBL] [Abstract][Full Text] [Related]
18. A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma. Ross JS; Wang K; Gay LM; Al-Rohil RN; Nazeer T; Sheehan CE; Jennings TA; Otto GA; Donahue A; He J; Palmer G; Ali S; Nahas M; Young G; Labrecque E; Frampton G; Erlich R; Curran JA; Brennan K; Downing SR; Yelensky R; Lipson D; Hawryluk M; Miller VA; Stephens PJ Clin Cancer Res; 2014 Jan; 20(1):68-75. PubMed ID: 24192927 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer. Ross JS; Gay LM Pathology; 2017 Feb; 49(2):120-132. PubMed ID: 28034454 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies. Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]